Compass Therapeutics Statistics
NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.02+0.0219 (+2.19%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 1.01 -0.75%
Compass Therapeutics by the numbers
Compass Therapeutics has a market capitalization of $183.7 million based on 180.09M shares outstanding. With trailing EPS of $-0.39, Compass Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 47.1% below its 50-day average and 71.6% below its 200-day average.
Average daily trading volume is 4.08M shares, or about $4.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CMPX valuation vs. peer median
| Metric | CMPX | Peer median | Difference |
|---|---|---|---|
| Market cap | $183.69M | $158.22M | +16% |
| Avg. volume | 4.08M | 499.07K | +718% |
Peer median across 8 companies: DTIL, IPHA, CRDL, CHRS, CGEN, TARA, VYGR, ABOS.
Valuation
- Market cap
- $183.69M
- EPS (TTM)
- $-0.39
- Shares outstanding
- 180.09M
Price and trading
- Previous close
- 0.9981
- Open
- 0.9705
- Day range
- 0.965 – 1.06
- 52-week range
- 0.829 – 6.88
- 52-week change
- -71.75%
- Beta
- —
- Volume
- 2.79M
- Average volume
- 4.08M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 183.69M
- Forward Pe
- -1.90
- Eps
- -0.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.88
- Week52 Low
- 0.83
- Avg Volume
- 4.08M
- Shares Outstanding
- 180.09M
- Ma50
- 1.93
- Ma200
- 3.59
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -85.17%
- Pct From52w Low
- 23.04%